Amarin Corp Plc\Uk (AMRN) Cash & Equivalents (2009 - 2026)
Amarin Corp Plc\Uk (AMRN) recorded Cash & Equivalents of $156.51 million in Q3 2026, up 27.5% from $122.8 million a year earlier and up 9.0% from the prior quarter.
Amarin Corp Plc\Uk (AMRN) Cash & Equivalents (2009 - 2026) Analysis & Trends
At the end of FY2025, Amarin Corp Plc\Uk reported Cash & Equivalents of $134.66 million, up 11.3% from FY2024.
- Annual Cash & Equivalents has a five-year compound annual growth rate of -6.4% (FY2020 to FY2025).
- Across earlier years, Cash & Equivalents came in at $121.04 million in FY2024 (-39.3%), $199.25 million in FY2023 (-8.5%), $217.67 million in FY2022 (-0.8%) and $219.45 million in FY2021 (+17.4%).
- The Q3 2026 figure is the highest quarterly Cash & Equivalents since Q3 2024.
- On a year-over-year basis, Cash & Equivalents rose in three of the last eight quarters, with an average decline of 11.4%.
- Peak year-over-year performance for Cash & Equivalents in the last five years was growth of 27.5% in Q3 2026, against a decline of 44.1% in Q1 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at $143.6 million (Q2 2026), $131.1 million (Q1 2026) and $134.66 million (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 4.89 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 16.91 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 10.77 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 9.55 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | 400.00 Mn |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 7.94 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 13.19 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 6.44 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 1.82 Bn |
| 10 | Amarin Corp Plc\Uk | 247.71 Mn | -378.28 Mn | 16.18 Mn | 156.51 Mn |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 156.51 Mn |
| Jun 30, 2026 | 143.60 Mn |
| Mar 31, 2026 | 131.10 Mn |
| Dec 31, 2025 | 134.66 Mn |
| Sep 30, 2025 | 122.80 Mn |
| Jun 30, 2025 | 147.90 Mn |
| Mar 31, 2025 | 119.52 Mn |
| Dec 31, 2024 | 121.04 Mn |
| Sep 30, 2024 | 156.94 Mn |
| Jun 30, 2024 | 215.92 Mn |
| Mar 31, 2024 | 213.94 Mn |
| Dec 31, 2023 | 199.25 Mn |
| Sep 30, 2023 | 270.81 Mn |
| Jun 30, 2023 | 233.00 Mn |
| Mar 31, 2023 | 191.41 Mn |
| Dec 31, 2022 | 217.67 Mn |
| Sep 30, 2022 | 240.50 Mn |
| Jun 30, 2022 | 228.00 Mn |
| Mar 31, 2022 | 219.20 Mn |
| Dec 31, 2021 | 219.45 Mn |
Amarin Corp Plc\Uk Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=AMRN&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "AMRN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=AMRN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();